Osta Biotechnologies Inc. Receives Funding From Institute for the Study of Aging

MONTREAL, QUEBEC--(Marketwire - October 21, 2008) - Osta Biotechnologies Inc. (TSX VENTURE: OBI) has received funding in the form of a convertible note in the amount of USD$247,106 to develop a novel class of drugs for Alzheimer's disease (AD).